Prelude Capital Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,700
| Closed | -$210K | – | 1261 |
|
|
2024
Q2 | $210K | Sell |
34,700
-5,100
| -13% | -$31.5K | 0.01% | 979 |
|
|
2024
Q1 | $234K | Buy |
39,800
+21,199
| +114% | +$126K | 0.01% | 1028 |
|
|
2023
Q4 | $146K | Sell |
18,601
-8,212
| -31% | -$57K | 0.01% | 995 |
|
|
2023
Q3 | $196K | Buy |
+26,813
| New | +$223K | 0.01% | 905 |
|
|
2023
Q2 | – | Sell |
-13,063
| Closed | -$135K | – | 1111 |
|
|
2023
Q1 | $135K | Buy |
+13,063
| New | +$167K | 0.01% | 920 |
|
|
2020
Q1 | – | Sell |
-8,807
| Closed | -$141K | – | 1412 |
|
|
2019
Q4 | $141K | Buy |
8,807
+2,569
| +41% | +$39.2K | 0.01% | 967 |
|
|
2019
Q3 | $115K | Buy |
+6,238
| New | +$122K | 0.01% | 907 |
|
|
2019
Q2 | – | Sell |
-606
| Closed | -$14K | – | 1645 |
|
|
2019
Q1 | $14K | Buy |
+606
| New | +$13.2K | ﹤0.01% | 1357 |
|
|
2018
Q4 | – | Sell |
-4,167
| Closed | -$91K | – | 1757 |
|
|
2018
Q3 | $91K | Buy |
4,167
+1,368
| +49% | +$30.4K | 0.01% | 980 |
|
|
2018
Q2 | $62K | Sell |
2,799
-12,461
| -82% | -$255K | ﹤0.01% | 1067 |
|
|
2018
Q1 | $263K | Buy |
15,260
+5,294
| +53% | +$88.3K | 0.02% | 618 |
|
|
2017
Q4 | $166K | Buy |
9,966
+832
| +9% | +$14.2K | 0.01% | 651 |
|
|
2017
Q3 | $156K | Sell |
9,134
-3,200
| -26% | -$53.8K | 0.01% | 724 |
|
|
2017
Q2 | $200K | Sell |
12,334
-6,399
| -34% | -$101K | 0.02% | 578 |
|
|
2017
Q1 | $325K | Sell |
18,733
-17,191
| -48% | -$287K | 0.03% | 416 |
|
|
2016
Q4 | $606K | Buy |
35,924
+15,191
| +73% | +$253K | 0.07% | 286 |
|
|
2016
Q3 | $364K | Buy |
20,733
+2,555
| +14% | +$41.4K | 0.04% | 371 |
|
|
2016
Q2 | $261K | Buy |
18,178
+9,078
| +100% | +$113K | 0.04% | 422 |
|
|
2016
Q1 | $112K | Sell |
9,100
-2,800
| -24% | -$30.9K | 0.02% | 721 |
|
|
2015
Q4 | $144K | Buy |
11,900
+3,800
| +47% | +$46.8K | 0.02% | 677 |
|
|
2015
Q3 | $107K | Buy |
8,100
+4,723
| +140% | +$71.3K | 0.02% | 821 |
|
|
2015
Q2 | $55K | Buy |
+3,377
| New | +$56.1K | 0.01% | 1118 |
|
|
2015
Q1 | – | Sell |
-2,430
| Closed | -$46K | – | 1921 |
|
|
2014
Q4 | $46K | Buy |
+2,430
| New | +$41.2K | 0.01% | 1269 |
|
|
2014
Q2 | – | Sell |
-600
| Closed | -$9K | – | 1889 |
|
|
2014
Q1 | $9K | Buy |
+600
| New | +$9.78K | ﹤0.01% | 1763 |
|
Other funds holding ANGO
SFM
KLP
RA
AC
Prelude Capital Management's ANGO Position: Q3 2024 in Review
Prelude Capital Management sold out of AngioDynamics (ANGO) in Q3 2024, closing a stake of 34,700 shares — an estimated $210K sold.
Prelude Capital Management first reported a position in ANGO in Q1 2014 and held it in 24 quarters. The position peaked at $606K in Q4 2016. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2024.
- Prelude Capital Management reported no remaining AngioDynamics position as of Q3 2024 after selling out during the quarter.
- Prelude Capital Management sold 34,700 AngioDynamics shares in Q3 2024, an estimated $210K.
- Prelude Capital Management first reported a position in AngioDynamics in Q1 2014 and held it in 24 quarters.
- Prelude Capital Management's AngioDynamics position peaked at $606K in Q4 2016.
- 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2024.
Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.